1. Home
  2. ANIP vs HUT Comparison

ANIP vs HUT Comparison

Compare ANIP & HUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • HUT
  • Stock Information
  • Founded
  • ANIP 2001
  • HUT 2011
  • Country
  • ANIP United States
  • HUT United States
  • Employees
  • ANIP N/A
  • HUT N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • HUT Finance: Consumer Services
  • Sector
  • ANIP Health Care
  • HUT Finance
  • Exchange
  • ANIP Nasdaq
  • HUT Nasdaq
  • Market Cap
  • ANIP 1.4B
  • HUT 1.7B
  • IPO Year
  • ANIP N/A
  • HUT N/A
  • Fundamental
  • Price
  • ANIP $65.31
  • HUT $21.10
  • Analyst Decision
  • ANIP Strong Buy
  • HUT Strong Buy
  • Analyst Count
  • ANIP 8
  • HUT 14
  • Target Price
  • ANIP $80.13
  • HUT $26.64
  • AVG Volume (30 Days)
  • ANIP 253.3K
  • HUT 6.5M
  • Earning Date
  • ANIP 08-05-2025
  • HUT 08-07-2025
  • Dividend Yield
  • ANIP N/A
  • HUT N/A
  • EPS Growth
  • ANIP N/A
  • HUT N/A
  • EPS
  • ANIP N/A
  • HUT N/A
  • Revenue
  • ANIP $674,068,000.00
  • HUT $132,459,000.00
  • Revenue This Year
  • ANIP $30.52
  • HUT $74.79
  • Revenue Next Year
  • ANIP $7.40
  • HUT $116.78
  • P/E Ratio
  • ANIP N/A
  • HUT N/A
  • Revenue Growth
  • ANIP 30.27
  • HUT 0.24
  • 52 Week Low
  • ANIP $52.50
  • HUT $8.73
  • 52 Week High
  • ANIP $77.00
  • HUT $31.95
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 55.12
  • HUT 63.59
  • Support Level
  • ANIP $63.17
  • HUT $20.04
  • Resistance Level
  • ANIP $66.18
  • HUT $22.42
  • Average True Range (ATR)
  • ANIP 1.83
  • HUT 1.28
  • MACD
  • ANIP 0.00
  • HUT 0.28
  • Stochastic Oscillator
  • ANIP 54.23
  • HUT 78.69

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

Share on Social Networks: